Gene · 4017
Papers2,536
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 2,536
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lineage Differentiation Potential of Different Sources of Mesenchymal Stem Cells for Osteoarthritis Knee. | Pharmaceuticals (Basel) | 2022 | 35455383 | PubTator, text mining | PubMed |
| Identification of TPM2 and CNN1 as Novel Prognostic Markers in Functionally Characterized Human Colon Cancer-Associated Stromal Cells. | Cancers (Basel) | 2022 | 35454931 | PubTator, text mining | PubMed |
| Hypoxia Alters the Proteome Profile and Enhances the Angiogenic Potential of Dental Pulp Stem Cell-Derived Exosomes. | Biomolecules | 2022 | 35454164 | PubTator, text mining | PubMed |
| Potential Therapeutic Targets and Promising Agents for Combating NAFLD. | Biomedicines | 2022 | 35453652 | PubTator, text mining | PubMed |
| Hypoxia Induced Changes of Exosome Cargo and Subsequent Biological Effects. | Front Immunol | 2022 | 35444652 | PubTator, text mining | PubMed |
| Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer. | Cell Death Dis | 2022 | 35444235 | PubTator, text mining | PubMed |
| Overexpression of miR-328-5p influences cell growth and migration to promote NSCLC progression by targeting LOXL4. | Ann Transl Med | 2022 | 35433959 | PubTator, text mining | PubMed |
| Comprehensive Analysis on Prognosis and Immune Infiltration of Lysyl Oxidase Family Members in Pancreatic Adenocarcinoma With Experimental Verification. | Front Mol Biosci | 2022 | 35433829 | PubTator, text mining | PubMed |
| Improved Precision-Cut Liver Slice Cultures for Testing Drug-Induced Liver Fibrosis. | Front Med (Lausanne) | 2022 | 35433753 | PubTator, text mining | PubMed |
| Identification of a Prognostic Signature Composed of GPI, IL22RA1, CCT6A and SPOCK1 for Lung Adenocarcinoma Based on Bioinformatic Analysis of lncRNA-Mediated ceRNA Network and Sample Validation. | Front Oncol | 2022 | 35433415 | PubTator, text mining | PubMed |
| An Individualized Prognostic Signature for Clinically Predicting the Survival of Patients With Bladder Cancer. | Front Genet | 2022 | 35422849 | PubTator, text mining | PubMed |
| Cancer stem-like cells evade CD8+CD103+ tumor-resident memory T (TRM) lymphocytes by initiating an epithelial-to-mesenchymal transition program in a human lung tumor model. | J Immunother Cancer | 2022 | 35418483 | PubTator, text mining | PubMed |
| ELK3 Controls Gastric Cancer Cell Migration and Invasion by Regulating ECM Remodeling-Related Genes. | Int J Mol Sci | 2022 | 35409069 | PubTator, text mining | PubMed |
| The Regulatory Functions and the Mechanisms of Long Non-Coding RNAs in Cervical Cancer. | Cells | 2022 | 35406713 | PubTator, text mining | PubMed |
| YAP Transcriptional Activity Dictates Cell Response to TNF In Vitro. | Front Immunol | 2022 | 35401557 | PubTator, text mining | PubMed |
| TGF-β induced reprogramming and drug resistance in triple-negative breast cells. | BMC Pharmacol Toxicol | 2022 | 35395809 | PubTator, text mining | PubMed |
| An MMP-degraded and cross-linked fragment of type III collagen as a non-invasive biomarker of hepatic fibrosis resolution. | Liver Int | 2022 | 35384259 | PubTator, text mining | PubMed |
| Post-COVID-19 Pulmonary Fibrosis. | Cureus | 2022 | 35371880 | PubTator, text mining | PubMed |
| Single-cell and spatial analysis reveal interaction of FAP+ fibroblasts and SPP1+ macrophages in colorectal cancer. | Nat Commun | 2022 | 35365629 | PubTator, text mining | PubMed |
| B-Lymphocytes in the Pathophysiology of Pancreatic Adenocarcinoma. | Front Immunol | 2022 | 35359944 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4017/papers?page=40